Suchergebnisse - (Subject:"PARP inhibitor")

PubPharm (5)

1

NRG-GY012 : Randomized phase 2 study comparing olaparib, cediranib, and the combination of cediranib/olaparib in women with recurrent, persistent, or metastatic endometrial cancer

enthalten in: Cancer | 2024

von Rimel, B. | Enserro, D. | Bender, D. | +10

2

A review of treatment options in HER2-low breast cancer and proposed treatment sequencing algorithm

enthalten in: Cancer | 2023

von Roy, A. | Kumarasamy, V. | Dhakal, A. | +2

3

A phase 1 dose-escalation study of the poly(ADP-ribose) polymerase inhibitor senaparib in Australian patients with advanced solid tumors

enthalten in: Cancer | 2023

von Gao, B. | Voskoboynik, M. | Cooper, A. | +15

4

Poly(adenosine diphosphate ribose) polymerase inhibitors induce autophagy-mediated drug resistance in ovarian cancer cells, xenografts, and patient-derived xenograft models

enthalten in: Cancer | 2020

von Santiago-O'Farrill, J. | Weroha, S. | Hou, X. | +15

5

Critical questions in ovarian cancer research and treatment : Report of an American Association for Cancer Research Special Conference

enthalten in: Cancer | 2019

von Bast, R. | Matulonis, U. | Sood, A. | +40

1
[1]